Cleared Special

K254085 - CARTO™ 3 EP Navigation System V9.0 with PIU Plus (FDA 510(k) Clearance)

Jan 2026
Decision
31d
Days
Class 2
Risk

K254085 is an FDA 510(k) clearance for the CARTO™ 3 EP Navigation System V9.0 with PIU Plus. This device is classified as a Computer, Diagnostic, Programmable (Class II - Special Controls, product code DQK).

Submitted by Biosense Webster, Inc. (Irvine, US). The FDA issued a Cleared decision on January 18, 2026, 31 days after receiving the submission on December 18, 2025.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1425.

Submission Details

510(k) Number K254085 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 18, 2025
Decision Date January 18, 2026
Days to Decision 31 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQK — Computer, Diagnostic, Programmable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1425

Similar Devices — DQK Computer, Diagnostic, Programmable

All 44
HemoSphere Nano Monitor (HSNANO1)
K253186 · Edwards Lifesciences, LLC · Feb 2026
CARTO™ 3 EP Navigation System V8.4
K252972 · Biosense Webster, Inc. · Feb 2026
Holter ECG and ABP system (HolterABP)
K251591 · Edan Instruments, Inc. · Feb 2026
LumiGuide Equipment R2.1
K252645 · Philips Medical Systems Nederland B.V. · Oct 2025
EnSite™ X EP System
K252013 · Abbott Medical · Sep 2025
EnSite™ X EP System, AutoMark Index Software License (ENSITE-AMI-01)
K251463 · Abbott Medical · Sep 2025